These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications. Albertson PC Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304 [No Abstract] [Full Text] [Related]
6. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications. Aus G Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303 [No Abstract] [Full Text] [Related]
7. Screening for prostate carcinoma: prostate-specific antigen--friend or foe? D'Amico AV Cancer; 2005 Mar; 103(5):881-3. PubMed ID: 15637686 [No Abstract] [Full Text] [Related]
8. Assessment of morphometric measurements of prostate carcinoma volume. Renshaw A Cancer; 2002 Apr; 94(8):2309-10. PubMed ID: 12001133 [No Abstract] [Full Text] [Related]
9. PSA scores: should we use a lower threshold? Carter HB Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780 [No Abstract] [Full Text] [Related]
11. Prostate cancer in men with serum PSA of <4 ng/ml: under-diagnosed or over-treated? Yossepowitch O Eur Urol; 2008 Apr; 53(4):686-8. PubMed ID: 17997025 [No Abstract] [Full Text] [Related]
12. Predicting the risk of prostate cancer on biopsy. Ebell MH Am Fam Physician; 2005 Sep; 72(6):1091-2. PubMed ID: 16190507 [No Abstract] [Full Text] [Related]
17. Prostate cancer screening: is it possible to explain diametrically opposed views? Richardson A N Z Med J; 2005 Feb; 118(1209):U1289. PubMed ID: 15711622 [No Abstract] [Full Text] [Related]
18. The role of the pathologist in diagnosing prostate cancer and guiding therapy. Weinstein MH N C Med J; 2006; 67(2):140-5. PubMed ID: 16752719 [TBL] [Abstract][Full Text] [Related]
19. [Detection of prostate cancer: yes or no?]. Van Cangh PJ Bull Mem Acad R Med Belg; 2006; 161(3-4):159-69. PubMed ID: 17172224 [No Abstract] [Full Text] [Related]
20. Prevalence and characteristics of screen-detected prostate carcinomas at low prostate-specific antigen levels: aggressive or insignificant? Gosselaar C; Roobol MJ; Schröder FH BJU Int; 2005 Feb; 95(2):231-7. PubMed ID: 15667646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]